Brigham Womens Company Profile
✉ Email this page to a colleague
What is the competitive landscape for BRIGHAM WOMENS, and what generic and branded alternatives to BRIGHAM WOMENS drugs are available?
BRIGHAM WOMENS has two approved drugs.
Summary for Brigham Womens
| US Patents: | 0 |
| Tradenames: | 2 |
| Ingredients: | 2 |
| NDAs: | 2 |
Drugs and US Patents for Brigham Womens
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Brigham Womens | FLUDEOXYGLUCOSE F18 | fludeoxyglucose f-18 | INJECTABLE;INTRAVENOUS | 203816-001 | Oct 30, 2014 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Brigham Womens Hosp | AMMONIA N 13 | ammonia n-13 | INJECTABLE;INTRAVENOUS | 203783-001 | Oct 30, 2014 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
